AVNS icon

Avanos Medical

12.24 USD
+0.38
3.2%
At close Updated Sep 18, 3:23 PM EDT
1 day
3.2%
5 days
-1.45%
1 month
8.8%
3 months
1.32%
6 months
-16.34%
Year to date
-22.68%
1 year
-49.44%
5 years
-63.84%
10 years
-62.19%
 

About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Employees: 2,227

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

46% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 65

34% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 29

3% more funds holding

Funds holding: 274 [Q1] → 282 (+8) [Q2]

2.28% more ownership

Funds ownership: 94.35% [Q1] → 96.63% (+2.28%) [Q2]

12% less capital invested

Capital invested by funds: $623M [Q1] → $547M (-$76.3M) [Q2]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $273K

Financial journalist opinion

Based on 4 articles about AVNS published over the past 30 days

Positive
Zacks Investment Research
5 hours ago
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
Neutral
PRNewsWire
3 days ago
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
ALPHARETTA, Ga. , Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
Neutral
Zacks Investment Research
8 days ago
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
Positive
Seeking Alpha
20 days ago
The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice
Avanos Medical, Inc. appears deeply undervalued after years of restructuring, with a potential stabilization in sales and earnings projected for 2025. Recent tariff impacts and lowered guidance seem fully priced in, setting the stage for upside surprises and a share price rally into 2026. Insider buying and improving technical indicators suggest a sea change for investor confidence could be next.
The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice
Negative
Zacks Investment Research
1 month ago
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
Neutral
Seeking Alpha
1 month ago
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Q2 Revenue Up 2%
Negative
Zacks Investment Research
1 month ago
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.34 per share a year ago.
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Neutral
PRNewsWire
1 month ago
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025.
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
Neutral
PRNewsWire
1 month ago
Avanos Medical, Inc. Announces Second Quarter 2025 Results
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results.
Avanos Medical, Inc. Announces Second Quarter 2025 Results
Charts implemented using Lightweight Charts™